HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term management of leukocyte adhesion deficiency type III without hematopoietic stem cell transplantation.

AuthorsPaul Saultier, Sarah Szepetowski, Matthias Canault, Céline Falaise, Marjorie Poggi, Pierre Suchon, Vincent Barlogis, Gérard Michel, Stéphane Loyau, Martine Jandrot-Perrus, Jean-Claude Bordet, Marie-Christine Alessi, Hervé Chambost
JournalHaematologica (Haematologica) Vol. 103 Issue 6 Pg. e264-e267 (06 2018) ISSN: 1592-8721 [Electronic] Italy
PMID29472353 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Biomarkers
  • FERMT3 protein, human
  • Membrane Proteins
  • Neoplasm Proteins
  • Recombinant Proteins
  • Factor VIIa
Topics
  • Alleles
  • Biomarkers
  • Disease Management
  • Factor VIIa (therapeutic use)
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Leukocyte-Adhesion Deficiency Syndrome (diagnosis, genetics, therapy)
  • Membrane Proteins (genetics)
  • Mutation
  • Neoplasm Proteins (genetics)
  • Phenotype
  • Recombinant Proteins (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: